You searched for "glands"
Report on ‘2024: Artificial Intelligence and the Eye’
As the application of artificial intelligence (AI) is brought to the foray of clinical medicine, you can be forgiven for thinking that it is a relatively recent technology. However, researchers and computer scientists have been working on it for many...Labour peer immortalised in bronze to celebrate achievements of vision impaired people
A bronze bust of Labour peer, the Rt Hon Lord David Blunkett – the UK’s first blind cabinet minister – has been unveiled at the House of Lords. The unveiling was part of a special event last night by national...Senior pupil warns of barriers young people with visual impairment face in the workplace
A pupil from Portobello High School, Edinburgh, is speaking out about the challenges visually impaired young people face in securing work experience and employment opportunities, after overcoming barriers of her own through a summer internship with Sight Scotland. Millie Williams,...My Top Five: Visionary inventions in ophthalmology
When we see how technologically forward and advanced modern-day medicine is, we forget that it is also an age-old, ancient profession with a rich, intriguing history that we remain unaware of. Ophthalmology in particular has always been at the forefront...An anterior segment lump: a diagnostic and treatment challenge
Case presentation A 50-year-old female presented to eye casualty with a lump on the left medial lower eyelid with associated redness and occasional bleeding. The lump was present for a few months with recent enlargement (Figure 1). Her past medical...Can 3D facial imaging improve patient management in disfiguring eye disease?
Fight for Sight is the leading UK charity funder of eye research. Since the 2013 Sight Loss and Vision Priority Setting Partnership we have encouraged our researchers to work on priorities jointly identified by people affected by sight loss and...Corporate M&A pace gathers momentum
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
